RECENT NEWS
Yourgene Health launches MagBench automated DNA extraction for NIPT
Molecular diagnostics group Yourgene Health has launched its new MagBench automated DNA extraction instrument and kit. MagBench offers a simple, fast and cost-efficient bench-top robotic cell-free DNA (cfDNA) extraction workstation optimised for Yourgene’s Sage 32 non-invasive prenatal testing (NIPT) workflow.
DoMore Diagnostics and Proscia partner on personalised treatment for colorectal cancer patients
DoMore Diagnostics, a leader in deep learning precision diagnostics for digital pathology, and digital pathology provider Proscia have partnered to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating artificial intelligence (AI)-powered clinical decision support into routine pathology workflows.
US partnership to develop digital diagnostic devices
IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has partnered with Atlanta-based East West Manufacturing to produce medical diagnostic devices intended to rapidly detect and differentiate multiple infections from a single saliva sample.
Bio-Rad launches first StarBright Red dye and extends antibody markers range
Bio-Rad Laboratories has announced the launch of the 29th StarBright dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 dyes.
Danaher acquires Abcam
Global science firm Danaher has announced that it has entered into a definitive agreement to acquire Abcam, a leading global supplier to research scientists for approximately $5.7 billion.
MHRA announces three new UK Approved Bodies to certify medical devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new UK Approved Bodies, almost doubling the UK’s capacity to certify medical devices, supporting faster certification of safe and effective medical devices for healthcare professionals and the public.
Thermo Fisher Scientific launches EXENT Solution with IVDR certification
Thermo Fisher Scientific has announced the commercial launch of its new EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.
SYNLAB aiming to be the UK’s leading laboratory diagnostics organisation
Diagnostics provider SYNLAB has set out its ambition to become the UK’s leading laboratory diagnostics organisation by 2027. It has unveiled a new vision, purpose and values which set a clear direction for the continued growth and success of each of its services in the UK – The Christie Pathology Partnership, Pathology First, Southwest Pathology Services, Synnovis, Lextox and SYNLAB Laboratory Services.
Delivering a diagnostic cytopathology service
The Royal College of Pathologists (RCPath), the Institute of Biomedical Science (IBMS) and British Association for Cytopathology (BAC) have released a joint statement to guide the delivery of diagnostic cytopathology services across England.
RCPath and IBMS to host Northern Symposium
The Royal College of Pathologists (RCPath) and the IBMS are jointly hosting the 2023 RCPath/IBMS Northern Symposium: Pathology and People. Taking place on 18 October at Cloth Hall Court, Leeds; the event will offer an exciting opportunity to meet, share experiences and network with local colleagues working in pathology in the North of England.
Monoclonal antibodies to avian influenza viruses
Virostat, which provides infectious disease antibody tools to researchers and manufacturers, has launched new monoclonal antibodies to avian influenza viruses, following reports from the Centers for Disease Control and Prevention (CDC) that the H5N1 bird influenza has been detected in several species of wild birds as well as domestic poultry flocks.
NHS reforms cancer standards to speed up diagnosis
Thousands of people referred for urgent cancer checks every month are set to be diagnosed and treated sooner, as the NHS reforms its cancer standards to reflect what matters most to patients and to align with modern clinical practice.
Visiopharm and Boston Cell Standards collaborate on IHC regulatory proposal
Visiopharm and Boston Cell Standards have announced a partnership to develop a joint technology solution that enables laboratories to meet key provisions of regulatory changes proposed in a recent groundbreaking editorial.
New microscope using AI can detect malaria in returning travellers
An automated microscope combined with AI software can identify malaria parasites in blood samples almost as accurately as experts staffing microscopes used in standard diagnostic procedures, according to research carried out at University College London Hospitals (UCLH).
NHS England launches technology trials to boost health and care connectivity
NHS organisations are being invited to take part in wireless trials to explore how cutting-edge technologies can help improve patient care. NHS England is supporting the trials to ensure health and care organisations make the most out of current and emerging wireless technology to deliver digital healthcare services.
Ohio hospital group to study accuracy and efficiency of AI in prostate cancer diagnosis
Ohio State University Wexner Medical Center (OSWMC) is launching a multi-arm clinical utility and health economics study to measure the accuracy, efficiency and cost-savings impact of using AI tools in diagnosing cancer in a community hospital setting. The research will utilise Paige Prostate Detect, the only FDA-approved AI in pathology for detecting prostate cancer.
Polio detection times could be halved with new diagnostic test
New research supported by the Medicines and Healthcare products Regulatory Agency (MHRA) has shown that the time to detect polio can be halved using a technique called Direct molecular Detection and Nanopore Sequencing (DDNS), supporting the global effort to eradicate polio and help save lives.
Successful trial for medical courier services drone
EMED Group, one of the largest healthcare logistic providers to the NHS, and Skyports Drone Services have successfully completed a proof-of-concept project for East Suffolk and North Essex NHS Foundation Trust aimed at bringing additional innovation and sustainability benefits to medical courier services.
Webinar to highlight animal and human health collaborations
HORIBA UK is to host a free-to-attend CPD webinar focusing on how a One Health multidisciplinary approach can enable beneficial changes in veterinary diagnostics and therapeutics usage.
Advancing automation for liquid biopsy and biobanking
Tecan has unveiled its Phase Separator, an innovative liquid-separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.
Featured Supplier
As a leading supplier of diagnostic systems, Beckman Coulter has an unsurpassed heritage of over 75 years of technology and innovation. Leading the way in the area of biomedical testing we are uniquely positioned as a company with both research and diagnostics divisions, Beckman Coulter is able to offer a complete product portfolio comprising of: +...
Upcoming Events
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
